Clinical trial Recruiting at 2 sites Interventional Ages 18 and up

Supportive care intervention for patients with locally advanced rectal cancer

Official title: PATHWAYS: An Informational and Supportive Care Intervention for Patients With Locally Advanced Rectal Cancer

Run by Massachusetts General Hospital · NCT05914766 · Data updated 2026-11-12

This study is testing a new support program to help patients with locally advanced rectal cancer feel more confident and informed as they start their treatment.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment80 (estimated)
SponsorMassachusetts General Hospital
Academic / other
Locations2 sites (Boston, Massachusetts and 1 other locations)
StatusRecruiting
StartedSeptember 21, 2023
Main results expectedMay 21, 2028
Study endsDecember 2028
Registry record updatedOctober 9, 2026
Trial IDNCT05914766 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 and older who are newly diagnosed with locally advanced rectal cancer and are within 8 weeks of deciding to pursue multimodality therapy.

Probably not a fit

Patients with comorbid health conditions that interfere with study participation or those who have previously been treated for colorectal cancer may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the feasibility and acceptability of a psychoeducational intervention designed to enhance self-efficacy in patients with locally advanced rectal cancer who are starting multimodality treatment. It consists of two phases, with the first phase testing the intervention on a small group of participants. The second phase will expand the participant pool to assess the refined intervention's effectiveness compared to standard care. Participants in the intervention group will receive coaching sessions focused on treatment-related information and support.

Why it matters

Potential benefit: If successful, this intervention could significantly improve patients' self-efficacy and quality of life during their treatment for rectal cancer.

How similar studies have gone: Other studies have shown promise in using psychoeducational interventions to support cancer patients, indicating that this approach may be effective.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Age≥18 years
2. Within 8 weeks after documented decision to pursue multi-modality therapy for newly diagnosed LARC (i.e., stage II or III disease)
3. Able to complete study procedures English or with the assistance of an interpreter

Exclusion Criteria:

1. Comorbid health condition that would interfere with study participation, as identified by cancer care team
2. Has undergone treatment for a prior colorectal cancer

Where it's running

  • Massachusetts General Hospital
    Boston, Massachusetts, United States
    Recruiting
  • Dana-Farber Cancer Institute
    Boston, Massachusetts, United States
    Recruiting

Study contacts

  • Principal investigator: Kelsey Lau-Min, MD, MSCE — Massachusetts General Hospital
  • Study coordinator: Kelsey Lau-Min, MD, MSCE
  • Email: klau-min@mgh.harvard.edu
  • Phone: 617-724-4000

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.